Τόμος 15 (2001) – Τεύχος 3 – Άρθρο 10 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 15 (2001) – Issue 3 – Article 10 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

2^nd Department of Obstetrics and Gynecology, University of Athens, Aretaieion Hospital

pharmakonpress[at]pharmakonpress[.]gr

2.    Mazur W.: Phytoestrogen content in foods. Bailtieres Clin. Endocrinol. Meiab. 12: 729-742 (1998)

3.    Calabrese G.: Nonalcoholic compounds of wine; the phytoestrogen resveratrol and moderate red wine consumption during menopause. Drugs Exp. Clin. Res. 25: 111-114 (1999)

4.    Tang G.W.K.: The climacteric of Chinese factory workers. Maturitas 19: 205-209 (1994)

5.    Boulet M.J., Oddens B.J., Lehert P., Vemer H.M., Visser A.: Climacteric and menopause in seven south-east Asian countries. Maturitas 19: 157-176 (1994)

6.    Brzezinski A., Debi A.; Phytoestrogens: the ‘’natural” selec-tive estrogen receptor modulators? Eur. J. Obstet. Gynecol. Reprod. Biol. 85: 47-51 (1999)

7.    Murkies A.L., Lombard C., Strauss B.J.G., Wilcox G., Burger H.G., Morton M.S.: Dietary flour supplementation decreases post-menopausal hot flushes; effect of soy and wheat. Maturitas 21: 189-195 (1995)

8.    Albertazzi P., Pansini F., Bonaccorsi G.p Zanotti L., Forini E., De Aloysio D.: The effect of dietary soy supplementation on hot flushes. Obstet. Gynecol.: 916-911 (1998)

9.    Arjmandi B.H., Alekel L., Hollis B.W.: Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J. Nutr. 126: 161-167 (1996)

10.  Ho S.C.; Body measurements, bone mass and fractures. Does the East differ from the West? Clin. Orthop. Relat. R. 323: 75-80 (1996)

11.  Lau E.M.C., Cooper C.: The epidemiology of osteoporosis. The oriental perspective in a world context. Clin. Orthop. Relat. R. 323: 65-74 (1996)

12.  Lambrinoudaki I., Kung A.W.C.: Absence of the high risk “s” allele associated with osteoporosis at the intronic Sp1 binding site of collagen la) gene in a southern Chinese population. J. Endocrinol. Invest, (in press)

13.  Lambrinoudaki I., Kung A.W.C.: Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy, A randomized, double blind, placebo controlled study. J. Rheumatol. 27: 1759-1765 {2000)

14.  Valente M., Bufalino L, Castglione G.N., et al.: Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass. Calcif. Tissue Int. 54: 377-380 (1994)

15.  Erdman J.W., Stillman R.J., LeeK F.: Short-term effects of soybean isoflavones on bone in postmenopausal women. Proceedings from the Second international Symposium on the role of soy in preventing and treating chronic diseases. September 15-18, 1996 Brussels, Belgium, 1996

16.  Anderson J.W., Johnstone B.M., Cook-Newell M.E.: Metaanalysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 333: 276-282 (1995)

17.  Sirtori C.R., Lovalti M.R., Manzoni C.: Soy and cholesterol reduction: clinical experience. J. Nutr. 125: 598S-605S (1995)

18.  Kirk E.A., Sutherland P., Wang S.A. et al.: Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor deficient mice. J. Nutr. 128: 954-959 (1998)

19.  Wroblewski-Lissin L, Cooke J.P.: Phytoestrogens and cardiovascular health. J. Am. Coll. Cardiol. 35: 1403-1410 (2000)

20.  Tikkanen M.J., Wahala K., Ojala S., et al.: Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. PNAS 95: 3106-3110 (1998)

21.  Wei H., Bowen R., Cai Q., et al.: Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Bio Med 208: 124-130 (1995).

22.  Takashi M., Ikeda U., Masuyama J.I., et al.: Monocyte-endothelial interaction induces expression of adhesion molecules on human umbilical cord endothelial cells. Cardlovasc. Res. 32: 422-429 (1996)

23.  Henderson B.E., Bernstein L: The international variation in breast cancer rates: an epidemiological assessment. Breast Cancer Res. Treatment 18: S11-S17 (1991)

24.  Ziegler R.G., Hoover R.N., Pike M.C., et at.: Migration patterns and breast cancer risk in Asian American Women, J. Natl. Cancer Inst. 85: 1819-1827 (1993)

25.  Schnaper H.W., McGowan K.A., Kim-Schulze S., Cid M.C.: Estrogen and endothelial cell angiogenic activity. Clin. Exp. Pharm. Phys. 23: 247-250 (1996)

26.  Fotsis T., Pepper M., Adiercreutz H., et al.: Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J. Nutr. 125: 790S-797S (1995)

27.  Fotsis T., Pepper M., Adiercreutz H., et al.: Genistein, a dietary derived inhibitor of in-vitro angiogenesis. PNAS 90: 2690-2694 (1993)

28.  Peterson G., Barnes S.: Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptor and multidrug resistance gene product. Biochem. Biophys. Res. Commun. 179: 661-667 (1991)

29.  Zava D.T., Duwe G.: Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr. Cancer 27: 31-40 (1997)

30.  Petrakis N.L., Barnes S., King E.B., et al.: Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidem. Biomarkers Prev. 5: 785-794 (1996)

31.  McMichael-Phillips D.F.: Proceedings of the Second International Symposium on the Role of Soy in Preventing and Treating Chronic Disease. St Louis (MO): Protein Technology International, 35 (1996)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr